The ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC 2026, oorganized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore.

The course will focus on sequencing strategies for actionable genomic alteration-positive NSCLC, biomarker-driven treatment using NGS, immunohistochemistry, and liquid biopsy, and emerging therapies such as antibody–drug conjugates, bispecific antibodies, cellular therapies, and vaccines. It will also address multidisciplinary management of oligometastatic disease and brain metastases. Applications close on 10 August 2026 at 23:59 CEST, and non-local participants may receive a travel grant of up to €600.

Apply Now.